| NCT Number | NCT07201233 |
| Lead Sponsor | Shandong Qilu Stem Cells Engineering Co., Ltd.
Collaborators: Tianjin Medical University General Hospital |
| Conditions | Bone Marrow Suppression |
| Enrollment | 30 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2027-11-01 (estimated) |
| Study Completion | 2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-10-01 |